Related Experiment Video
Updated: May 2, 2026
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.6K
Remodeling and fibrosis in chronic eosinophil inflammation
1Division of Allergy, Immunology, Department of Pediatrics and Medicine, University of California, San Diego, Rady Children's Hospital, San Diego, Calif., USA.
Digestive Diseases (Basel, Switzerland)
|March 8, 2014
Summary
Eosinophilic esophagitis (EoE) involves tissue remodeling, including fibrosis, driven by eosinophils and factors like TGF-β1. Therapies targeting these mechanisms may reverse remodeling and improve EoE symptoms.
Area of Science:
- Gastroenterology
- Immunology
- Pathology
Background:
- Chronic eosinophilic inflammation is linked to tissue remodeling in diseases like eosinophilic esophagitis (EoE), asthma, and hypereosinophilic syndrome (HES).
- Tissue remodeling in EoE involves epithelial and subepithelial changes, including hyperplasia, fibrosis, angiogenesis, and smooth muscle hypertrophy.
- Previous research was limited by scarce human tissue, but EoE's diagnostic needs provide opportunities to study tissue changes and clinical features.
Purpose of the Study:
- To investigate the mechanisms and clinical implications of tissue remodeling in eosinophilic esophagitis (EoE).
- To identify key molecular factors and cellular players involved in EoE-associated tissue remodeling.
- To explore potential therapeutic strategies for reversing or reducing EoE-related tissue remodeling.
Main Methods:
- Analysis of human esophageal biopsies from EoE patients to correlate tissue remodeling with clinical features.
- Measurement of profibrotic and proangiogenic factors (e.g., TGF-β1, VEGF) in EoE tissues.
- Utilizing gene-deficient mouse models to assess the roles of eosinophils, IL-5, and TGF-β1 signaling in fibrosis.
Main Results:
- Elevated levels of profibrotic and proangiogenic factors, including TGF-β1, VEGF, and VCAM-1, were observed in EoE.
- Eosinophils and mast cells were identified as sources of these remodeling factors.
- TGF-β1 was implicated as a key regulator of epithelial-mesenchymal transition, fibrosis, and smooth muscle dysfunction in EoE.
Conclusions:
- Tissue remodeling is a critical mechanism underlying major complications of EoE, such as dysphagia, strictures, and food impactions.
- Eosinophils, IL-5, and TGF-β1 signaling are essential for EoE-associated fibrosis.
- Therapeutic interventions including topical corticosteroids, anti-IL-5 agents, and dietary antigen avoidance show promise in mitigating EoE-related tissue remodeling.
Related Concept Videos
01:12Chronic Inflammation: Introduction
41
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
41
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:26Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112